Home › Cancer (all types) › Ohio › Cincinnati
Cancer (all types) clinical trials in Cincinnati, OH
27 studies for Cancer (all types) are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RecruitingPhase 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi away
Registry Study for Radiation Therapy Outcomes
RecruitingObservational study
- University of Cincinnati Medical Center, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RecruitingPhase 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi away
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Recruiting
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pan Tumor Rollover Study
RecruitingPhase 2
- Oncology Hematology Care, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · 15 mi away
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · 15 mi away
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RecruitingPhase 2/3
- Oncology Hematology Care, Inc., Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecruitingPhase 3
- Research Site, Edgewood · 8 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RecruitingObservational study
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- and 1 more
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
RecruitingPhase 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RecruitingPhase 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
RecruitingObservational study
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RecruitingPhase 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
RecruitingPhase 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
RecruitingPhase 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
RecruitingObservational study
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
RecruitingObservational study
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · 15 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Lung Cancer19 studies
- Obesity19 studies
- Prostate Cancer18 studies
- Multiple Myeloma17 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.